Vivos Therapeutics (VVOS) Current Leases (2021 - 2026)
Vivos Therapeutics' (VVOS) quarterly Current Leases came in at $56000.0 in Q1 2026, down 88.01% year-on-year from $467000.0 in Q1 2025, and up 1.82% on a QoQ basis from $55000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Current Leases (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 6 years of Current Leases data on file, last reported at $56000.0 in Q1 2026.
- On a quarterly basis, Current Leases fell 88.01% year-over-year to $56000.0 in Q1 2026; TTM through Mar 2026 was $56000.0, a 88.01% decrease from a year earlier, with the FY2025 full-year figure at $55000.0, down 88.47% from the prior year.
- Current Leases for Q1 2026 stood at $56000.0, up from $55000.0 in the prior quarter.
- Over the last five years, Current Leases for VVOS reached as high as $485000.0 in Q3 2024 and fell as low as $55000.0 in Q2 2025.
- Historically, Current Leases has averaged $355058.8 across 5 years, with a median of $446000.0 in 2022.
- Across the five-year window, Current Leases surged 481.94% in 2022 and slumped 88.66% in 2025, its largest moves.
- Year by year, Current Leases stood at $419000.0 in 2022, then grew by 13.13% to $474000.0 in 2023, then increased by 0.63% to $477000.0 in 2024, then plunged by 88.47% to $55000.0 in 2025, then gained by 1.82% to $56000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $56000.0 in Q1 2026, $55000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | 483,000.00 |
| Dec 31, 2023 | 474,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 419,000.00 |
| Sep 30, 2022 | 446,000.00 |
| Jun 30, 2022 | 383,000.00 |
| Mar 31, 2022 | 357,000.00 |
| Dec 31, 2021 | 72,000.00 |